These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 12430176)

  • 1. Cytotoxicity and cellular differentiation activity of methylenebis(phosphonate) analogs of tiazofurin and mycophenolic acid adenine dinucleotide in human cancer cell lines.
    Yalowitz JA; Pankiewicz K; Patterson SE; Jayaram HN
    Cancer Lett; 2002 Jul; 181(1):31-8. PubMed ID: 12430176
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel mycophenolic adenine bis(phosphonate) analogues as potential differentiation agents against human leukemia.
    Pankiewicz KW; Lesiak-Watanabe KB; Watanabe KA; Patterson SE; Jayaram HN; Yalowitz JA; Miller MD; Seidman M; Majumdar A; Prehna G; Goldstein BM
    J Med Chem; 2002 Jan; 45(3):703-12. PubMed ID: 11806722
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of biochemical parameters of benzamide riboside, a new inhibitor of IMP dehydrogenase, with tiazofurin and selenazofurin.
    Gharehbaghi K; Sreenath A; Hao Z; Paull KD; Szekeres T; Cooney DA; Krohn K; Jayaram HN
    Biochem Pharmacol; 1994 Oct; 48(7):1413-9. PubMed ID: 7945441
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis of a methylenebis(phosphonate) analogue of mycophenolic adenine dinucleotide: a glucuronidation-resistant MAD analogue of NAD.
    Lesiak K; Watanabe KA; Majumdar A; Powell J; Seidman M; Vanderveen K; Goldstein BM; Pankiewicz KW
    J Med Chem; 1998 Feb; 41(4):618-22. PubMed ID: 9484510
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel mycophenolic adenine bis(phosphonate)s as potential immunosuppressants.
    Pankiewicz KW; Lesiak-Watanabe K; Watanabe KA; Malinowski K
    Curr Med Chem; 1999 Jul; 6(7):629-34. PubMed ID: 10390605
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Probing binding requirements of type I and type II isoforms of inosine monophosphate dehydrogenase with adenine-modified nicotinamide adenine dinucleotide analogues.
    Chen L; Gao G; Felczak K; Bonnac L; Patterson SE; Wilson D; Bennett EM; Jayaram HN; Hedstrom L; Pankiewicz KW
    J Med Chem; 2007 Nov; 50(23):5743-51. PubMed ID: 17958343
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nucleoside and non-nucleoside IMP dehydrogenase inhibitors as antitumor and antiviral agents.
    Franchetti P; Grifantini M
    Curr Med Chem; 1999 Jul; 6(7):599-614. PubMed ID: 10390603
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cell differentiation and altered IMP dehydrogenase expression induced in human T-lymphoblastoid leukemia cells by mycophenolic acid and tiazofurin.
    Kiguchi K; Collart FR; Henning-Chubb C; Huberman E
    Exp Cell Res; 1990 Mar; 187(1):47-53. PubMed ID: 1967583
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel mycophenolic adenine bis(phosphonate)s as potent anticancer agents and inducers of cells differentiation.
    Pankiewicz KW; Lesiak-Watanabe K
    Nucleosides Nucleotides; 1999; 18(4-5):927-32. PubMed ID: 10432711
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The chemistry of nicotinamide adenine dinucleotide (NAD) analogues containing C-nucleosides related to nicotinamide riboside.
    Pankiewicz KW; Watanabe KA; Lesiak-Watanabe K; Goldstein BM; Jayaram HN
    Curr Med Chem; 2002 Apr; 9(7):733-41. PubMed ID: 11966436
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolism of the novel IMP dehydrogenase inhibitor benzamide riboside.
    Jäger W; Salamon A; Szekeres T
    Curr Med Chem; 2002 Apr; 9(7):781-6. PubMed ID: 11966442
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mycophenolic acid and thiazole adenine dinucleotide inhibition of Tritrichomonas foetus inosine 5'-monophosphate dehydrogenase: implications on enzyme mechanism.
    Hedstrom L; Wang CC
    Biochemistry; 1990 Jan; 29(4):849-54. PubMed ID: 1971185
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modulation of nicotinamide adenine dinucleotide and poly(adenosine diphosphoribose) metabolism by the synthetic "C" nucleoside analogs, tiazofurin and selenazofurin. A new strategy for cancer chemotherapy.
    Berger NA; Berger SJ; Catino DM; Petzold SJ; Robins RK
    J Clin Invest; 1985 Feb; 75(2):702-9. PubMed ID: 3919063
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationships between the cytotoxicity of tiazofurin and its metabolism by cultured human lung cancer cells.
    Carney DN; Ahluwalia GS; Jayaram HN; Cooney DA; Johns DG
    J Clin Invest; 1985 Jan; 75(1):175-82. PubMed ID: 2856924
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biochemical consequences of resistance to tiazofurin in human myelogenous leukemic K562 cells.
    Jayaram HN; Zhen W; Gharehbaghi K
    Cancer Res; 1993 May; 53(10 Suppl):2344-8. PubMed ID: 8097964
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NAD-based inhibitors with anticancer potential.
    Felczak K; Vince R; Pankiewicz KW
    Bioorg Med Chem Lett; 2014 Jan; 24(1):332-6. PubMed ID: 24269162
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biochemical differences among four inosinate dehydrogenase inhibitors, mycophenolic acid, ribavirin, tiazofurin, and selenazofurin, studied in mouse lymphoma cell culture.
    Lee HJ; Pawlak K; Nguyen BT; Robins RK; Sadée W
    Cancer Res; 1985 Nov; 45(11 Pt 1):5512-20. PubMed ID: 2865005
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Studies on the mechanism of action of benzamide riboside: a novel inhibitor of IMP dehydrogenase.
    Gharehbaghi K; Grünberger W; Jayaram HN
    Curr Med Chem; 2002 Apr; 9(7):743-8. PubMed ID: 11966437
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis of nonhydrolyzable analogues of thiazole-4-carboxamide and benzamide adenine dinucleotide containing fluorine atom at the C2' of adenine nucleoside: induction of K562 differentiation and inosine monophosphate dehydrogenase inhibitory activity.
    Lesiak K; Watanabe KA; Majumdar A; Seidman M; Vanderveen K; Goldstein BM; Pankiewicz KW
    J Med Chem; 1997 Aug; 40(16):2533-8. PubMed ID: 9258359
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cofactor-type inhibitors of inosine monophosphate dehydrogenase via modular approach: targeting the pyrophosphate binding sub-domain.
    Felczak K; Chen L; Wilson D; Williams J; Vince R; Petrelli R; Jayaram HN; Kusumanchi P; Kumar M; Pankiewicz KW
    Bioorg Med Chem; 2011 Mar; 19(5):1594-605. PubMed ID: 21324702
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.